Autologous Cultured Chondrocytes (Carticel Sm Service)
Autologous Cultured Chondrocytes is an FDA-licensed reference biologic from Vericel Corporation. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1997
Reference approved
Reference product
Carticel Sm Service Autologous Cultured Chondrocytes
Vericel Corporation
- Approved
- Aug 22, 1997
- Marketing
- Disc
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for Autologous Cultured Chondrocytes, in chronological order.
Reference approval
Approval date of the reference Autologous Cultured Chondrocytes product.
29 yr 2 mo ago
Frequently asked questions
Are there biosimilars approved for Autologous Cultured Chondrocytes (Carticel Sm Service)?
No 351(k) biosimilars or interchangeable biosimilars referencing Autologous Cultured Chondrocytes are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.